Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shaoxing BSM Chemical Co., Ltd. (300796.SZ)
Hangzhou, CN
Shaoxing BSM Chemical Co., Ltd. focuses globally on both the innovation and sourcing of essential chemical precursors required for pendimethalin manufacturing. Their product line includes various mononitroxylene isomer compounds and an array of dimethylaniline reduction products, prominently featuring items such as 4-nitro-o-xylene and N-(1-ethylpropyl)-3,4-dimethylaniline. This enterprise commenced operations in 2003 and maintains its primary base of operations in Hangzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.40% | -7.68% | -18.56% | -29.25% | -19.45% | -15.65% | -34.55% | -38.66% | -2.53% | -50.00% | -50.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-10 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+14.7% ★ Q1'26: -16.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+188.9% ★ Q1'26: -85.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-8.0% Q1'26: -27.5% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+2.1% Q1'26: +3.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.7% Q1'26: +1.3% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-17.6% ★ Q1'26: -20.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×5.05× Q1'26: 19.31× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
530.02M
est: 709.00M (-25.2%)
|
768.07M
est: 1.00B (-23.3%)
|
699.19M
est: 1.00B (-30.2%)
|
1.33B
est: 1.67B (-20.6%)
|
1.52B
est: 1.38B (+10.1%)
|
1.49B
1.49B – 1.49B
+7.5% YoY
|
2.17B
2.17B – 2.17B
+46.0% YoY
|
| EBITDA |
113.81M
est: 144.64M (-21.3%)
|
240.70M
est: 184.28M (+30.6%)
|
172.37M
est: 184.28M (-6.5%)
|
64.78M
est: 307.71M (-78.9%)
|
146.59M
est: 254.56M (-42.4%)
|
273.68M
273.68M – 273.68M
+7.5% YoY
|
399.49M
399.49M – 399.49M
+46.0% YoY
|
| EBIT |
71.04M
est: 91.05M (-22.0%)
|
192.79M
est: 110.92M (+73.8%)
|
118.58M
est: 110.92M (+6.9%)
|
-29.87M
est: 185.22M (-116.1%)
|
32.63M
est: 153.23M (-78.7%)
|
164.74M
164.74M – 164.74M
+7.5% YoY
|
240.47M
240.47M – 240.47M
+46.0% YoY
|
| Net Income |
56.39M
est: 153.50M (-63.3%)
|
152.88M
est: 22.35M (+584.0%)
|
88.41M
est: 22.35M (+295.5%)
|
-32.86M
est: 165.47M (-119.9%)
|
24.07M
est: 48.14M (-50.0%)
|
69.20M
69.20M – 69.20M
+43.8% YoY
|
201.58M
201.58M – 201.58M
+191.3% YoY
|
| SGA |
47.28M
est: 38.34M (+23.3%)
|
58.87M
est: 93.07M (-36.7%)
|
99.41M
est: 93.07M (+6.8%)
|
154.24M
est: 155.41M (-0.8%)
|
61.44M
est: 128.57M (-52.2%)
|
138.23M
138.23M – 138.23M
+7.5% YoY
|
201.77M
201.77M – 201.77M
+46.0% YoY
|
| EPS |
0.19
est: 0.42 (-54.8%)
|
0.43
est: 0.07 (+478.8%)
|
0.24
est: 0.07 (+223.0%)
|
-0.09
est: 0.55 (-116.4%)
|
0.08
est: 0.16 (-50.0%)
|
0.23
0.23 – 0.23
+43.8% YoY
|
0.67
0.67 – 0.67
+191.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hongliang Shan | Deputy GM & Director | — | male |
| Jigang Ren | Deputy GM & Non-Independent Director | — | male |
| Shuai Yi | Board Secretary | — | — |
| Wenjun Tu | Financial Director | — | female |
| Xiaogan Zhang | Board Secretary | — | male |
| Xijun Zhong | GM & Director | — | male |
| Yong Hu | Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300796.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
